Clinical evaiuation of siddha drug Mega rajanga kirutham in the treatment of Leucorrhoea (vellai noi)
Phase 3
- Conditions
- Health Condition 1: null- VELLAI NOI(LEUCORRHOEA)
- Registration Number
- CTRI/2017/03/008025
- Lead Sponsor
- Ayothidoss pandithar hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
• Married female,
• Patient having the symptoms of whitish or yellowish discharge per vagina,
•Pruritis vulva, vulval irritation, dysuria, abdominal pain, low backache
•Patient who is willing to cooperate for vaginal swab examination & who undergo routine blood investigation.
• Positive Wet test for Trichomonas vaginalis
• Patient who is willing to participate in trial and signing in consent form
Exclusion Criteria
•Cases not confirmed by Wet test for Tr.vaginalis.
•H/O Diabetes mellitus
•H/O Bacterialvaginosis/Vulvovaginal candidiasis
•H/O Sexually transmitted disease (syphilis, HIV, gonorrhoea)
•H/O Non-specific leucorrhea
•Pregnancy and lactation
•H/OMalignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)It is assessed by the vaginal smear when wet test becomes negative for Trichomonas vaginalis after treatment, 2) reduction of clinical symptoms such as white or yellowish discolouration per vagina, lower abdominal pain, low back pain, pruritus vulva, foul smell,dysuria and dispareunia.Timepoint: 27 days.
- Secondary Outcome Measures
Name Time Method 1)Socio economic status 2) Age related to the disease will be assessed.Timepoint: 27 days